Related Experiment Videos
Use of high-content analysis for compound screening and target selection
1UCB Celltech, Granta Park, Great Abington, Cambridge, CB1 6GS, UK. oliver.rausch@ucb-group.com
Idrugs : the Investigational Drugs Journal
|June 24, 2005
Summary
High-content analysis (HCA) is a key drug discovery tool for screening. Integrating genetics with HCA enhances target validation and enables high-throughput screening for new drug leads.
Area of Science:
- Biotechnology
- Pharmacology
- Genetics
Background:
- High-content analysis (HCA) is a crucial technology in modern drug discovery.
- Its application is primarily focused on secondary cell-based screening.
Purpose of the Study:
- To highlight the role of HCA in drug discovery.
- To explore the potential of HCA in target validation and lead identification.
Main Methods:
- Utilizing high-content analysis for cell-based screening.
- Integrating genetic information with HCA data.
Main Results:
- HCA is established as a core technology for secondary screening.
- Combined genetic knowledge and HCA offer powerful target validation capabilities.
Conclusions:
- HCA significantly advances drug discovery processes.
- HCA facilitates high-throughput screening for novel drug candidates by leveraging cellular assays and genetic insights.